MedVi vs PlushCare: Compare GLP-1 Programs & Pricing
Side-by-side MedVi and PlushCare: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
MedVi and PlushCare are two telehealth options patients often compare when seeking GLP-1–based weight-management support. This comparison focuses on entry pricing, promotional offers, membership requirements, clinical oversight, medication sourcing, and the patient experience to help you make an informed choice.
MedVi vs PlushCare: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| MedVi | $179.00 | $279.00 | $120 off first month | No |
| PlushCare | — | — | — | No |
MedVi vs PlushCare: Medical Process & Accessibility
MedVi emphasizes a streamlined telehealth intake to enable rapid clinician review and fast access to prescribed GLP-1 compounds. Intake typically includes a medical questionnaire, photo ID verification, and a clinician evaluation to confirm safety and appropriateness. PlushCare also uses licensed clinicians but is known for scheduled follow-ups and dose titration pathways for patients who want structured, ongoing visits.
Both platforms operate under telehealth regulations in the states where they are licensed and coordinate with U.S.-based pharmacies. Providers will decline or pause prescriptions if clinical contraindications are identified. Telehealth care requires accurate self-reporting and sometimes an in-person visit if clinically necessary.
MedVi vs PlushCare: Pricing Comparison
MedVi lists semaglutide starting at $179.00 and tirzepatide starting at $279.00. PlushCare’s publicized starter prices for compounded GLP-1 therapies are not listed here for comparison. Because pricing can vary by formulation, dose, shipping, and pharmacy, review final cost details during clinician intake and prescription fulfillment.
MedVi is offering a promotional discount of $120 off the first month. PlushCare may run its own promotions periodically; check provider pages for current offers. Neither provider requires a paid membership for initial prescriptions based on available information, but optional subscription services or ongoing coaching may carry fees — confirm before enrolling.
MedVi vs PlushCare: Clinical Oversight & Support
Both services provide clinician review before any GLP-1 prescription is issued. Standard practice includes assessment of medical history (including cardiovascular disease, pancreatitis history, pregnancy status, and other risk factors), discussion of side effects, and a plan for dose escalation. Clinicians follow current telehealth standards and will only prescribe when clinically appropriate.
MedVi vs PlushCare: Medication Quality & Safety
MedVi and PlushCare generally work with licensed U.S. pharmacies to dispense prescribed compounded GLP-1 medications. These compounds are prescribed by clinicians but are not identical to brand-name, FDA-approved formulations such as Wegovy® or Mounjaro®; patients should understand the difference. All GLP-1 therapies are prescription-only and should be used under clinician supervision to monitor efficacy and adverse events.
MedVi vs PlushCare: Customer Experience
Patient reports suggest MedVi is competitive on price and rapid onboarding, while PlushCare is noted for thorough clinician engagement and structured follow-up. Shipping times and refill processes are similar when prescriptions are approved, but individual experiences vary. Always verify expected delivery windows and pharmacy return policies.
Review MedVi Read PlushCare Details
MedVi vs PlushCare: Final Verdict
If price and fast enrollment are top priorities, MedVi is attractive given the published starting costs and first-month promotion. If you prefer comprehensive follow-up and an emphasis on longitudinal dose management, PlushCare may be a better fit. Both are licensed telehealth options that prescribe GLP-1 therapies when clinically appropriate; choose based on cost, care model, and the level of follow-up you need.
Join MedVi Get Started with PlushCare
Disclaimer
This article is for informational purposes only and does not constitute medical advice. All GLP-1 medications are prescription drugs; clinicians will assess individual suitability and monitor treatment. Always consult a licensed healthcare professional before beginning any medication. GLP1Talks & GLP1Discussions may receive affiliate commissions at no cost to you.